Robert E. Sobol
- Oncology top 5%
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 6
- Biotechnology top 2%
- Cancer Research and Treatments 11
- Immunology top 5%
- Immunotherapy and Immune Responses 7
- Hematology top 5%
- Genetics top 5%
- Virus-based gene therapy research 14
- Chronic Lymphocytic Leukemia Research 6
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Ivor RoystonDaniel L. ShawlerHabib FakhraiDan MercolaOliver DorigoRuth A. GjersetHeng-Cheng LinKeith L. Black
- Cited by
- OncologyBiotechnologyImmunology
- Journals
- Journal of Clinical Oncology (5 papers)Human Gene Therapy (2 papers)Cancer Gene Therapy (2 papers)
- Partner nations
- United StatesSouth KoreaCanada
In The Last Decade
Robert E. Sobol
43 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 90
- Oncology 797
- Biotechnology 225
- Immunology 535
- Hematology 257
- Genetics 197
Countries citing papers authored by Robert E. Sobol
This map shows the geographic impact of Robert E. Sobol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Sobol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Sobol more than expected).
Fields of papers citing papers by Robert E. Sobol
This network shows the impact of papers produced by Robert E. Sobol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Sobol. The network helps show where Robert E. Sobol may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert E. Sobol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 18 | |
| 2 | 2017 | 4 | |
| 3 | 2007 | 42 | |
| 4 | 2006 | 13 | |
| 5 | 2002 | 18 | |
| 6 | The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiation. | 2001 | 13 |
| 7 | Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study. | 1999 | 55 |
| 8 | 1998 | 20 | |
| 9 | 1997 | 8 | |
| 10 | 1997 | 7 | |
| 11 | 1995 | 63 | |
| 12 | 1995 | 20 | |
| 13 | 1995 | 9 | |
| 14 | 1995 | 80 | |
| 15 | 1992 | 2 | |
| 16 | 1989 | 84 | |
| 17 | 1988 | 6 | |
| 18 | 1987 | 8 | |
| 19 | 1987 | 26 | |
| 20 | A novel monoclonal antibody-defined antigen which distinguishes human non-small cell from small cell lung carcinomas. | 1986 | 10 |
About Robert E. Sobol
Robert E. Sobol is a scholar working on Biotechnology, Oncology and Immunology, having authored 43 papers that have together received 1.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), Cancer Research and Treatments (11 papers), CAR-T cell therapy research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Immunotherapy and Immune Responses (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Oncology (797 citations), Biotechnology (225 citations) and Immunology (535 citations). Robert E. Sobol has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include Ivor Royston, Daniel L. Shawler, Habib Fakhrai, Dan Mercola, Oliver Dorigo, Ruth A. Gjerset, Heng-Cheng Lin, Keith L. Black, Clara D. Bloomfield and Leonard J. Deftos. Their work appears in journals such as Journal of Clinical Oncology, Human Gene Therapy, Cancer Gene Therapy, Journal of Immunotherapy and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.